DeepRad.AI INC.
Update：2025/10/18
Industries
Main Industry
Health Care
Main Product/Service
DeepLung-CAC
The product is an all-in-one screening system targeting the chest region, encompassing the lung, heart, and bone. Utilizing deep learning analysis on low-dose chest CT scans, this multi-module system is capable of automatically detecting lung nodules, predicting coronary artery calcification risk, and assessing bone density risk. As well as an auto report system that allows radiologists to preview and edit the comprehensive report. DeepBrain-Cognito
A Novel AI technology allowed researchers to capture the FUTURE 4D brain degeneration for the first time. This combo algorithms portray not only the patterns of regional brain cortical thinning in 4D but also the phenotypical behavior in standard clinical dementia rating (CDR) scores, potentially facilitating early detection of dementia in sub-healthy group, delaying the aging process, and contributing to the development of early intervention and preventive medicine.
The product is an all-in-one screening system targeting the chest region, encompassing the lung, heart, and bone. Utilizing deep learning analysis on low-dose chest CT scans, this multi-module system is capable of automatically detecting lung nodules, predicting coronary artery calcification risk, and assessing bone density risk. As well as an auto report system that allows radiologists to preview and edit the comprehensive report. DeepBrain-Cognito
A Novel AI technology allowed researchers to capture the FUTURE 4D brain degeneration for the first time. This combo algorithms portray not only the patterns of regional brain cortical thinning in 4D but also the phenotypical behavior in standard clinical dementia rating (CDR) scores, potentially facilitating early detection of dementia in sub-healthy group, delaying the aging process, and contributing to the development of early intervention and preventive medicine.
Founded Year
2023
Unified Business No.
94243590
Status
Active
Number of Employees
0
Total Paid-in
Capital
55,000,000 (NT$)
Location of Company
Taiwan
, Taipei City
Year of establishment, company status, responsible person, paid-in capital amount, and registered address are sourced from the "Commerce Industrial Services Portal, Department of Commerce, MOE. Exit status refers to various situations, including emerging stock exchanges (e.g., potential exits), mergers and acquisitions (M&A), and IPOs. The overseas development countries are collected through information provided by startups themselves and the information filled in when registering for matchmaking events. Therefore, the information cannot be updated in real time. If you wish to make corrections, please email findit.tier@gmail.com. Thank you.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
Founded in 2023, our journey was sparked by a commitment to reshape radiology through the power of AI. Led by experienced radiologists and AI engineers, the expedition began with the intent to revolutionize medical imaging on preventive medicine.
